Market Research Logo

Europe Oligonucleotide Synthesis Market – Industry Trends and Forecast to 2026

Europe Oligonucleotide Synthesis Market – Industry Trends and Forecast to 2026

Short Description
By Product Type (DNA Oligonucleotides, RNA Oligonucleotides), Type (Oligonucleotide-Based Drugs, Primers, Probes, Intermediate-Scale Synthesized Oligos, Large-Scale Synthesized Oligos, Linkers & Adaptors, Array-Based Oligos), Consumables (Instruments, Kits & Reagents, Others), Service Type (Custom Oligos, Predesigned Oligos, Oligo Synthesis), Application (Research Applications, Therapeutic Applications, Diagnostic Applications, Others), End User (Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Hospitals, Others), Country (Germany, U.K., France, Switzerland, Italy, Belgium, Denmark, Sweden, Spain, Netherlands, Russia, Turkey, Rest of Europe)

Market Definition:
Synthesized oligonucleotides are used for various applications in the life science and medical industry for research purposes as a probe for DNA synthesis and sequencing, probes for the detection of complementary RNA and DNA through hybridization in clinical developments and synthesis of artificial genes.
The oligo nucleotides services provided by the manufacturers are available based on the customer requirement which helps in the identification of specific genes in life science research procedures. Various types of fragment oligo nucleotides are available which are prepared and used by different sectors such as for research of life science, the oligos are used as PCR primers and probes, DNA sequencing, gene editing (CRISPR), for the diagnostics applications, the oligos are used as microarrays/gene panels, fluorescence in situ hybridization and for therapeutic applications, the oligo nucleotides are used as nucleic acid aptamers, antisense, gene and cell therapy and others.
The wide range of applications in the field of research, diagnostics, therapeutics, drug discovery, data storage and synthetic biology and growing research oriented programs are boosting the requirement of the oligonucleotide in medical sector.
The overall market of synthesized oligonucleotides is growing tremendously due to high growth in the life science industries and growing applications in therapeutics and in genetics and genomics in the research and diagnostics.

Market Segmentation:
Europe oligonucleotides synthesis market is segmented into six notable segments which are based on the basis of product type, type, consumables, service type, application and end user.

• On the basis of product type, the market is segmented into DNA Oligonucleotides and RNA Oligonucleotides.
• On the basis of type, the market is segmented into oligonucleotide-based drugs, primers, probes, intermediate-scale synthesized oligos, large-scale synthesized oligos, linkers & adaptors and array-based oligos.
• On the basis of consumables, the market is segmented into instruments, kits & reagents and others.
• On the basis of service type, the market is segmented into custom oligos, predesigned oligos and oligo synthesis.
• On the basis of application, the market is segmented into research applications, therapeutic applications, diagnostic applications and others.
• On the basis of end user, the market is segmented into bio-pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, hospitals, and others.

Market Players
The key market players of Europe oligonucleotides synthesis market are:
• Agilent Technologies, Inc.
• Atdbio Ltd.
• LGC Limited
• Bio-Synthesis Inc.
• Eurofins Genomics
• Kaneka Eurogentec S.A.
• General Electric
• Genscript
• AJINOMOTO CO., INC (Genedesign, Inc.)
• Danaher
• Merck Kgaa
• Lgc Biosearch Technologies
• Nitto Denko
• Thermo Fisher Scientific
• Trilink Biotechnologies, Llc
• Biolytic Lab Performance Inc.
• Polygen Gmbh
• Quintara Biosciences
• Bio Basic Inc.
• Danaher (Integrated DNA Technologies, Inc)
• Twist Bioscience
• Others

The single user license is non-downloadable and non-printable. Global Site license allows these actions.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Europe Oligonucleotide Synthesis Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Europe Oligonucleotide Synthesis Market: Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Primary Interviews With Key Opinion Leaders
2.7 Dbmr Market Position Grid
2.8 Dbmr Vendor Share Analysis
2.9 Multivariate Modeling
2.10 Products Lifeline Curve
2.11 Secondary Sources
2.12 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Increasing Usage Of Synthesized Oligos In Molecular Diagnostics And Clinical Applications
3.1.2 Increasing Government Investments, R&D Expenditure In Pharmaceutical And Biotechnology Companies
3.2 Genetic Disorders
3.3 Restraints
3.3.1 Lack Of Skilled Professionals
3.3.2 Increasing In-house Production Hindering The Europe Market Growth
3.4 Opportunities
3.4.1 Strategic Initiatives Of The Market Players
3.5 Developments And Innovations Of New Products
3.6 Challenges
3.6.1 Stringent Regulations
3.6.2 Drug Delivery & Toxicology Challenges
4 Executive Summary
4.1 Europe Oligonucleotide Synthesis Market: Segmentation
5 Premium Insights
6 Europe Oligonucleotide Synthesis Market, By Product Type
6.1 Overview
6.2 Dna Oligonucleotides
6.3 Rna Oligonucleotides
7 Europe Oligonucleotide Synthesis Market, By Type
7.1 Overview
7.2 Oligonucleotide-based Drugs
7.3 Primers
7.4 Probes
7.5 Intermediate-scale Synthesized Oligos
7.6 Large-scale Synthesized Oligos
7.7 Linkers & Adaptors
7.8 Array-based Oligos
8 Europe Oligonucleotide Synthesis Market, By Consumables
8.1 Overview
8.2 Instruments
8.3 Kits & Reagents
8.4 Others
9 Europe Oligonucleotide Synthesis Market, By Service Type
9.1 Overview
9.2 Custom Oligos
9.2.1 Modification
9.2.2 Purification
9.3 Predesigned Oligos
9.4 Oligo Synthesis
9.4.1 0 Nmol
9.4.2 5,000 Nmol
9.4.3 -200 Nmol
9.4.4 -50 Nmol
9.4.5 000 Nmol
9.4.6 More Than 10,000 Nmol
10 Europe Oligonucleotide Synthesis Market, By Application
10.1 Overview
10.2 Research Applications
10.2.1 Pcr
10.2.2 Qpcr
10.2.3 Sequencing
10.2.4 Gene Synthesis
10.2.5 Fluorescence In Situ Hybridization (Fish)
10.2.6 Dna Microarrays
10.2.7 Other Applications
10.3 Therapeutic Applications
10.3.1 Dna & Antisense Oligonucleotide-based Therapies
10.3.2 Rnai Oligonucleotide-based Therapies
10.3.3 Cpg Oligonucleotide-based Therapies
10.3.4 Others
10.4 Diagnostic Applications
10.5 Others
11 Europe Oligonucleotide Synthesis Market, By End User
11.1 Overview
11.2 Biopharmaceutical & Biotechnology Companies
11.3 Academic & Research Institutes
11.4 Contract Research Organizations
11.5 Hospitals
11.6 Others
12 Europe Oligonucleotide Synthesis Market, By Geography
12.1 Europe
12.1.1 Germany
12.1.2 U.K.
12.1.3 France
12.1.4 Switzerland
12.1.5 Italy
12.1.6 Belgium
12.1.7 Denmark
12.1.8 Sweden
12.1.9 Spain
12.1.10 Netherlands
12.1.11 Russia
12.1.12 Turkey
12.1.13 Rest Of Europe
13 Europe Oligonucleotide Synthesis Market: Company Landscape
13.1 Company Share Analysis: Europe
14 Swot & Dbmr Analysis
15 Company Profile
15.1 Danaher
15.1.1 Company Snapshot
15.1.2 Reveneue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Developments
15.2 Merck Kgaa
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Service Portfolio
15.2.5 Product Portfolio
15.2.6 Recent Development
15.3 General Electric
15.3.1 Company Snapshot
15.3.2 Reveneue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Developments
15.4 Thermo Fisher Scientific Inc.
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Service Portfolio
15.4.5 Product Portfolio
15.4.6 Recent Developments
15.5 Agilent Technologies, Inc.
15.5.1 Company Snapshot
15.5.2 Revenue Analysis
15.5.3 Company Share Analysis
15.5.4 Product Portfolio
15.5.5 Recent Developments
15.6 Eurofins Scientific
15.6.1 Company Snapshot
15.6.2 Revenue Analysis
15.6.3 Company Share Analysis
15.6.4 Service Portfolio
15.6.5 Recent Developments
15.7 Atdbio Ltd.
15.7.1 Company Snapshot
15.7.2 Product Portfolio
15.7.3 Service Portfolio
15.7.4 Recent Development
15.8 Ajinomoto Co.,Inc.
15.8.1 Company Snapshot
15.8.2 Revenue Analysis
15.8.3 Product Portfolio
15.8.4 Recent Development
15.9 Bianoscience Gmbh
15.9.1 Company Snapshot
15.9.2 Product Portfolio
15.9.3 Recent Development
15.10 Bio Basic Inc
15.10.1 Company Snapshot
15.10.2 Service Portfolio
15.10.3 Recent Development
15.11 Biolytic Lab Performance Inc.
15.11.1 Company Snapshot
15.11.2 Product Portfolio
15.11.3 Recent Developments
15.12 Bio-synthesis Inc
15.12.1 Company Snapshot
15.12.2 Service Portfolio
15.12.3 Recent Development
15.13 Genscript
15.13.1 Company Snapshot
15.13.2 Reveneue Analysis
15.13.3 Product Portfolio
15.13.4 Recent Developments
15.14 Kaneka Eurogentec S.A.
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Service Portfolio
15.14.4 Recent Developments
15.15 Lgc Limited
15.15.1 Company Snapshot
15.15.2 Service Portfolio
15.15.3 Product Portfolio
15.15.4 Recent Developments
15.16 Nitto Denko Corporation
15.16.1 Company Snapshot
15.16.2 Revenue Analysis
15.16.3 Service Portfolio
15.16.4 Recent Developments
15.17 Polygen Gmbh
15.17.1 Company Snapshot
15.17.2 Product Portfolio
15.17.3 Recent Development
15.18 Qiagen
15.18.1 Company Snapshot
15.18.2 Revenue Analysis
15.18.3 Product Portfolio
15.18.4 Recent Developments
15.19 Quintara Biosciences
15.19.1 Company Snapshot
15.19.2 Product Portfolio
15.19.3 Recent Development
15.20 Trilink Biotechnologies, Llc
15.20.1 Company Snapshot
15.20.2 Product Portfolio
15.20.3 Recent Developments
15.21 Twist Bioscience
15.21.1 Company Snapshot
15.21.2 Reveneue Analysis
15.21.3 Product Portfolio
15.21.4 Recent Developments
16 Conclusion
17 Questionnaire
18 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report